Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) mutations research hub

A study to test Aumolertinib in European participants with genetically linked advanced Lung Cancer

This study is testing a new medicine called Aumolertinib for people in Europe with a type of advanced lung cancer called Non-Small Cell Lung Cancer. This cancer has specific genetic changes (EGFR mutations). The study aims to see if the medicine is safe and how it works.